Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.24% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 160.59, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.55M shares, decreasing 4.38% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 157.05K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.38.